| 000 | 01979cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031053.0 | ||
| 008 | 141013s2014 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.08.08.Ph.D.2014.Ma.F | ||
| 100 | 0 | _aMaram Mourad Hassan Mansour | |
| 245 | 1 | 0 |
_aFormulation of an anti - inflammatory drug as fast dissolving tablets / _cMaram Mourad Hassan Mansour ; Supervised Magdy Ibrahim Mohammed , Boushra Mohammed Elhoussieny Yousef |
| 246 | 1 | 5 | _aص{u٠٦أأ}اغة أقراص سر{u٠٦أأ}عة الذوبان بالفم لعقار مضاد للالتھابات |
| 260 |
_aCairo : _bMaram Mourad Hassan Mansour , _c2014 |
||
| 300 |
_a189 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aKetorolac tromethamine is a potent non steroidal anti - inflammatory drug (NSAID) that is widely used in treatment of moderate to sever pain. It was reported that ketorolac produces its analgesic activity via inhibition of prostaglandin synthesis. However, due to its high potency, it has been proposed that this drug has another mechanism of action such as nitric oxide release. ketorolac tromethamine fast dissolving tablets were developed using direct compression method with the addition of superdisintegrants. Three types of superdisintegrants namely croscaramellose sodium, crospovidone and sodium starch glycolate were incorporated in tablets formulation | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aDirect compression | |
| 653 | 4 | _aFast dissolving tablets | |
| 653 | 4 | _aKetroloac tromethamine | |
| 700 | 0 |
_aBoushra Mohammed Elhoussieny Yousef , _eSupervisor |
|
| 700 | 0 |
_aMagdy Ibrahim Mohammed , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c47754 _d47754 |
||